Benutzer: Gast  Login
Weniger Felder
Einfache Suche
Titel:

Can engineered "designer" T cells outsmart chronic hepatitis B?

Dokumenttyp:
Journal Article
Autor(en):
Protzer, U; Abken, H
Abstract:
More than 350 million people worldwide are persistently infected with human heptatitis B virus (HBV) and at risk to develop liver cirrhosis and hepatocellular carcinoma making long-term treatment necessary. While a vaccine is available and new antiviral drugs are being developed, elimination of persistently infected cells is still a major issue. Recent efforts in adoptive cell therapy are experimentally exploring immunotherapeutic elimination of HBV-infected cells by means of a biological attack...     »
Zeitschriftentitel:
Hepat Res Treat
Jahr:
2010
Band / Volume:
2010
Seitenangaben Beitrag:
901216
Sprache:
eng
Volltext / DOI:
doi:10.1155/2010/901216
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/21188203
Print-ISSN:
2090-1364
TUM Einrichtung:
Institut für Virologie
 BibTeX